首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Risk factors for late recurrent candidaemia. A retrospective matched case-control study
【24h】

Risk factors for late recurrent candidaemia. A retrospective matched case-control study

机译:晚期复发念珠菌血症的危险因素。回顾性匹配病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Incidence, risk factors and clinical significance of late recurrent (LR) candidaemia (>1 month between episodes) remains unclear. The 1219 episodes of candidaemia detected from January 1985 to December 2014 were reviewed. We selected all cases with more than one episode separated by at least 30 days after clinical resolution in the interim (cases) and compared each of them with two controls (patients with single episodes of candidaemia). Clinical strains were genotyped to differentiate relapses from re-infection. Eighteen patients (1.48%) had 36 episodes of LR candidaemia (median 4 months). Independent risk factors for recurrence in the multivariate analysis were: underlying gastrointestinal disease (OR 67.16; 95% CI 5.23-861.71; p0.001) and fungaemia due to Candida parapsilosis (OR 9.10; 95% 1.33-62.00; p 0.02). All episodes of LR candidaemia diagnosed during the first 3 months were due to an intravascular source of infection, whereas in those occurring after 3 months the main source of the disease was the abdomen, followed by endocarditis, and urinary tract. Molecular typing showed that 42.9% of LR candidaemias were relapses and 57.1% were re-infections. Neither time of recurrence nor clinical origin could predict type of recurrence. LR candidaemia is a relatively rare event that is more frequent in patients who have an initial episode of candidaemia due to C. parapsilosis or an underlying gastrointestinal disease. Episodes of LR candidaemia that occur within the first 3 months should prompt an attempt to exclude an intravascular source of infection, whereas those occurring later point to an intraabdominal origin. (C) 2015 Clinical Microbiology and Infection published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
机译:尚不清楚晚期复发(LR)念珠菌血症(发作之间> 1个月)的发生率,危险因素和临床意义。回顾了从1985年1月至2014年12月发现的1219例念珠菌血症发作。我们选择了在过渡期至少30天后至少有1次发作的所有病例(病例),并将每个病例与两个对照(患有单一念珠菌病的患者)进行了比较。对临床菌株进行基因分型,以区分复发与再次感染。 18名患者(1.48%)患有36例LR念珠菌血症(中位数为4个月)。在多变量分析中,复发的独立危险因素为:潜在的胃肠道疾病(OR 67.16; 95%CI 5.23-861.71; p0.001)和由于副念珠菌引起的真菌血症(OR 9.10; 95%1.33-62.00; p 0.02)。在头3个月内诊断出的所有LR念珠菌血症发作均是由于血管内感染引起的,而在3个月后发生的那些发作中,疾病的主要来源是腹部,其次是心内膜炎和尿路。分子分型显示,LR念珠菌血症复发率为42.9%,再次感染率为57.1%。复发时间和临床起源均无法预测复发类型。 LR念珠菌血症是一种相对罕见的事件,在因副寄生虫或潜在的胃肠道疾病而出现念珠菌血症的初始发作的患者中更为常见。在头三个月内发生的LR念珠菌血症发作应促使尝试排除血管内感染源,而稍后发生的事件则指向腹部内起源。 (C)Elsevier Ltd代表欧洲临床微生物学和传染病学会出版的《 2015临床微生物学和感染》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号